Drug delivery systems - An overview

Methods in Molecular Biology

Volumn 437, Issue , 2008, Pages 1-50

  Jain, Kewal K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

Controlled release; Drug delivery devices; Drug delivery systems; Drug formulations; Nanobiotechnology; Nanoparticles; Personalized medicine; Protein peptide delivery; Routes of drug administration; Targeted drug delivery

Indexed keywords

EID: 84934434333     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-210-6_1     Document Type: Article

References (20)

1. Jain KK. Transdermal drug delivery: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1-230.
2. Mainardes RM, Urban MC, Cinto PO, et al. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv 2006;3:275-85.
3. Van den Mooter G. Colon drug delivery. Expert Opin Drug Deliv 2006;3:111-25.
4. Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 2006;58:1030-60.
5. Ely L, Roa W, Finlay WH, Lobenberg R. Effervescent dry powder for respiratory drug delivery. Eur J Pharm Biopharm 2007;65:346-53.
6. Dailey LA, Jekel N, Fink L, et al. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 2006;215:100-8.
7. Jain KK. Cardiovascular drug delivery: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1-230.
8. Jain KK Drug delivery in CNS disorders: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1-310.
9. Groisman A, Enzelberger M, Quake SR. Microfluidic memory and control devices. Science 2003;300:955-8.
10. Yih TC, Wei C, Hammad B. Modeling and characterization of a nanoliter drug-delivery MEMS micropump with circular bossed membrane. Nanomedicine 2005;1:164-75.
11. Prescott JH, Lipka S, Baldwin S, et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol 2006;24:437-8.
12. Chitkara D, Shikanov A, Kumar N, Domb AJ. Biodegradable injectable in situ depot-forming drug delivery systems. Macromol Biosci 2006;6:977-90.
13. Jain KK Nanobiotechnology: applications, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1-690.
14. Vila A, Gill H, McCallion O, Alonso MJ. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 2004;98:231-44.
15. Xu Y, Du Y, Huang R, Gao L. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 2003;24:5015-22.
16. Dufresne MH, Le Garree D, Sant V, et al. Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery. Int J Pharm 2004;277:81-90.
17. Matsumura Y. Micelle carrier system in clinical trial. Nippon Rinsho 2006;64:316-21.
18. Jain KK Personalized medicine: scientific and commercial aspects. Basel: Jain PharmaBiotech Publications, 2007:1-570.
19. Gorbacheva VY, Kondratov RV, Zhang R, et al. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA 2005;102:3407-12.
20. Jain KK. Drug delivery in cancer: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1-550.